CSL Of Australia, Others Called Price Fixers In U.S. Court Filing
This article was originally published in PharmAsia News
Executive SummaryAustralia's CSL, its CSL Behring unit and U.S.-based Baxter International, all producers of blood plasma, conspired to set prices, the Mayo Clinic alleges in court papers
You may also be interested in...
An experienced hand at M&A, Ajay Piramal has done it again – this time selling Decision Resources Group to Clarivate Analytics for $950m. Apart from $900m in cash, Piramal Enterprises will get a stake in Clarivate while the latter expects the acquisition to be earnings-accretive in 2020.
San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.